Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain
NCT00425230 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2022-08-12
Summary
This is a study to assess the possible benefit of duloxetine in the treatment of chronic phantom limb pain.
Conditions
- Chronic Phantom Limb Pain
Interventions
- DRUG
-
Duloxetine
Sponsors & Collaborators
-
Baylor College of Medicine
lead OTHER
Principal Investigators
-
Asif Chaudhry, MD · Baylor College of Medicine
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-01-31
- Completion
- 2007-06-30
Countries
- United States
Study Locations
More Related Trials
-
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients
NCT04762758 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Treatment Use of 3,4-Diaminopyridine
NCT01765140 ·Status: NO_LONGER_AVAILABLE
-
Oral Dexamethasone for the Treatment of Cervical Radiculopathy
NCT00308594 ·Status: TERMINATED ·Phase: PHASE2
-
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
NCT01511978 ·Status: COMPLETED ·Phase: PHASE2
-
Memantine for Enhanced Stroke Recovery
NCT02144584 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome.
NCT00298623 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Diflunisal on Familial Amyloidosis
NCT00294671 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy
NCT00481013 ·Status: COMPLETED ·Phase: PHASE2
-
Combined N-of-1 Trials Mexiletine vs Placebo in Patients With Non-Dystrophic Myotonia (NDM)
NCT02045667 ·Status: COMPLETED ·Phase: PHASE2
-
Naltrexone in the Treatment of Pyromania
NCT00467454 ·Status: WITHDRAWN ·Phase: PHASE2
-
Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist
NCT03218969 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dimethyl Fumarate in Adrenomyeloneuropathy
NCT06513533 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
NCT00488839 ·Status: COMPLETED ·Phase: PHASE3
-
Technical Development of Clinical Laboratory Studies
NCT03253718 ·Status: WITHDRAWN
-
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
NCT01605825 ·Status: COMPLETED ·Phase: PHASE2
-
Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS)
NCT02090725 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
NCT00439569 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy
NCT04082000 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome
NCT01825395 ·Status: APPROVED_FOR_MARKETING
-
Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome
NCT03345953 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
NCT02422940 ·Status: TERMINATED ·Phase: PHASE3
-
Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity
NCT05311215 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia
NCT05285540 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
NCT01521663 ·Status: COMPLETED ·Phase: PHASE2
-
Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function
NCT02415257 ·Status: WITHDRAWN ·Phase: PHASE4